BITTERZ
1.11.2020 12:02:07 CET | Business Wire | Press release
Today (November 1), on behalf of Bitterz LLC (Hinds Building, Kingstown, St. Vincent and the Grenadines), we are pleased to announce that our global crypto exchange Bitterz in Japan will start to provide services to our customers in China, Hong Kong and Taiwan.
To celebrate the grand opening, we are currently offering $50 worth of bitcoins to all customers who open a new account (free of charge).
We hope that you will enjoy the experience of trading with our Japanese crypto exchange with these bitcoins.
Bitterz Official Website
https://bitterz.com/refs/top/10457
▪ Main features of Bitterz
1. A safe environment to continue trading
Bitterz is a completely Japanese crypto exchange, which is rare among global exchanges.
We offer a trading environment suitable for accumulating wealth, with a leverage of 200 times at most, a zero-cut system, and a reliable support system.
2. All the developers are Japanese
Bitterz's system development team is all Japanese and was formerly a group of engineers from a large, privately held company.
3. MT5: a specialized tool in cryptocurrency
With the fast response of MT5, we have achieved a stress-free trading environment.
You won't miss the trading timing even in the rapidly changing cryptocurrency market.
4. A highly secured trading environment
We have 24-hour-monitoring for dealing and security, a cold wallet to protect your holdings, and a two-step authentication system to prevent unauthorized logins, creating a highly secure trading environment.
Your cryptocurrency holdings are insured; with a multi-sig cold wallet, your holdings can only be transferred under multiple administrators’ approval.
Most of your holdings will be managed in the cold wallet, as we plan to store several days of withdrawals in the hot wallet.
5. Reliable support system
We offer the fastest support in the industry with native staffs from China and Taiwan to provide you with a secure trading environment.
6. Demo account for trading experience
You can experience cryptocurrency trading in the same environment as real trading without using your own money.
This is a great option for those who want a risk-free trading experience and who want to see how easy it is to use the tools in advance.
7. A reassuring zero-cut system
We have adopted a zero-cut system, where even in case of unexpected loss, there is no additional deposit in excess of your holdings, so you can trade proactively without worries.
8. Withdrawal (transfer) fees are practically free forever
There are many exchanges that don't charge a withdrawal (transfer) fee, but most of them require you to pay a mining fee.
Of course, we will never charge you a fee for withdrawal.
In addition, in order not to burden our clients with mining fees, we pay you back with MT5 bonus credit, which makes withdrawal (transfer) fees practically free.
9. Enrichment of campaigns
We aim to provide some kind of campaign at all times throughout the year.
Now, to celebrate the grand opening, we are currently offering $50 worth of bitcoins to all customers who open a new account (free of charge).
For more information, please visit the official website below.
Bitterz Official Website
https://bitterz.com/refs/top/10457
View source version on businesswire.com: https://www.businesswire.com/news/home/20201101005003/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom